abstract |
It is intended to provide a novel β-galactoside-α-2,3-sialyltransferase and a nucleic acid encoding this sialyltransferase. It is also intended to provide a microorganism capable of producing this sialyltransferase and a method of producing this sialyltransferase by using the above-described microorganism. Moreover, it is intended to provide a vector containing the nucleic acid encoding the above-described sialyltransferase, a host cell having been transformed by this vector, and a method of producing a recombinant β-galactoside-α-2,3-sialyltransferase. |